These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21669487)

  • 1. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.
    Tsuchiya A; Kamimura H; Tamura Y; Takamura M; Yamagiwa S; Suda T; Nomoto M; Aoyagi Y
    Cancer Lett; 2011 Oct; 309(1):95-103. PubMed ID: 21669487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
    Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
    Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of signal-regulatory protein alpha (SIRP alpha) in hepatocellular carcinoma].
    Li B; Wang H; Chen Z
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):345-7. PubMed ID: 10921027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
    Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
    Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the serum level of soluble E-cadherin in patients with HCC.
    Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.
    Uchida H; Iwashita Y; Sasaki A; Shibata K; Matsumoto T; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):161-8. PubMed ID: 16706828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
    Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.
    Inagaki Y; Tang W; Makuuchi M; Hasegawa K; Sugawara Y; Kokudo N
    Liver Int; 2011 Jan; 31(1):22-35. PubMed ID: 20874725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of hepatic cancer stem cells.
    Tong CM; Ma S; Guan XY
    J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.